The exhibitions, performances, readings, and more are just a sliver of the more than 500 events in the nationwide Fall of Freedom series.
OBI-902 is the first ADC utilizing OBI’s proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback